XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Sales        
Total sales $ 2,348 $ 371 $ 5,390 $ 1,060
Cost of sales        
Total cost of sales 1,660 709 4,783 1,774
Gross margin 688 (338) 607 (714)
Operating Expenses:        
Research and development 7,338 6,438 22,937 16,949
General and administrative 3,198 6,827 26,570 15,348
Sales and marketing 3,434 2,787 11,345 5,770
Total operating expenses 13,970 16,052 60,852 38,067
Loss from operations (13,282) (16,390) (60,245) (38,781)
Interest income 170 3 203 13
Other income (expense), net (59) (5) (63) 2
Loss before provision for income taxes (13,171) (16,392) (60,105) (38,766)
Provision for income taxes 0 0 0 0
Net loss and comprehensive loss $ (13,171) $ (16,392) $ (60,105) $ (38,766)
Earnings Per Share, Basic $ (0.19) $ (8.66) $ (0.85) $ (22.56)
Earnings Per Share, Diluted $ (0.19) $ (8.66) $ (0.85) $ (22.56)
Denominator for Basic EPS - Weighted-average common stock 70,509,639 1,892,208 70,398,103 1,718,489
Denominator for Dilutive EPS - Weighted-average common stock 70,509,639 1,892,208 70,398,103 1,718,489
Device        
Sales        
Total sales $ 1,945 $ 200 $ 4,305 $ 521
Cost of sales        
Total cost of sales 1,215 508 3,511 1,420
Service        
Sales        
Total sales 403 171 1,085 539
Cost of sales        
Total cost of sales $ 445 $ 201 $ 1,272 $ 354